Anti-Neoplastic Agents Market: Global Industry Analysis and Forecast 2016 - 2024
- Submitted by: veronicasavio
- Views: 82
- Category: Other
- Date Submitted: 05/12/2016 02:42 AM
- Pages: 5
- Report this Essay
Anti-Neoplastic Agents Market: Global Industry Analysis and
Forecast 2016 - 2024
Persistence Market Research
Anti-Neoplastic Agents Market: Global
Industry Analysis and Forecast 2016 - 2024
Persistence Market Research
1
Anti-Neoplastic Agents Market: Global Industry Analysis and
Forecast 2016 - 2024
Persistence Market Research Released New Market Report on “Anti-Neoplastic Agents
Market: Global Industry Analysis and Forecast 2016 - 2024”.
The second major cause of death in U.S. is Cancer after cardiovascular diseases and is
expected to ascend becoming the leading cause of death in next few years. According to Center
for Disease Control and Prevention (CDC), malignant neoplasms accounted for 15% of deaths
worldwide in 2012 with 19.3 Mn new cases of cancer are expected to be diagnosed by 2025.
The increasing number is a major challenge to physicians and researchers to fulfill the unmet
needs in treatment of malignant neoplasms. Anti-neoplastic agents are used prominently as a
first line therapy for cancer treatment as well as in combination with surgery or radiation therapy.
Plenty of anti-neoplastic agents are available commercially for the treatment of different types of
cancers including Oncotrex, Gleevec, Neosar, Cytarine, Leukeran etc. Several new antineoplastic agents are in clinical trials such as Oncofetal Ag (phase 1), Panobinostat (Phase 2),
Volasertib (phase 2), Bortezomib (phase 4) etc. which are expected to launch in next 5-10
years.
Interested in report: Please follow the below the links to meet your requirements;
Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/10741
Factors such as growing incidence of cancer across the globe and demand for cost-effective
treatment options are believed to play crucial role for the growth of global anti-neoplastic agents
market. Rapid innovation in the field of personalized medicine presents a huge opportunity to
manufacturers of anti-neoplastic...
Forecast 2016 - 2024
Persistence Market Research
Anti-Neoplastic Agents Market: Global
Industry Analysis and Forecast 2016 - 2024
Persistence Market Research
1
Anti-Neoplastic Agents Market: Global Industry Analysis and
Forecast 2016 - 2024
Persistence Market Research Released New Market Report on “Anti-Neoplastic Agents
Market: Global Industry Analysis and Forecast 2016 - 2024”.
The second major cause of death in U.S. is Cancer after cardiovascular diseases and is
expected to ascend becoming the leading cause of death in next few years. According to Center
for Disease Control and Prevention (CDC), malignant neoplasms accounted for 15% of deaths
worldwide in 2012 with 19.3 Mn new cases of cancer are expected to be diagnosed by 2025.
The increasing number is a major challenge to physicians and researchers to fulfill the unmet
needs in treatment of malignant neoplasms. Anti-neoplastic agents are used prominently as a
first line therapy for cancer treatment as well as in combination with surgery or radiation therapy.
Plenty of anti-neoplastic agents are available commercially for the treatment of different types of
cancers including Oncotrex, Gleevec, Neosar, Cytarine, Leukeran etc. Several new antineoplastic agents are in clinical trials such as Oncofetal Ag (phase 1), Panobinostat (Phase 2),
Volasertib (phase 2), Bortezomib (phase 4) etc. which are expected to launch in next 5-10
years.
Interested in report: Please follow the below the links to meet your requirements;
Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/10741
Factors such as growing incidence of cancer across the globe and demand for cost-effective
treatment options are believed to play crucial role for the growth of global anti-neoplastic agents
market. Rapid innovation in the field of personalized medicine presents a huge opportunity to
manufacturers of anti-neoplastic...